You are here
Treatment with a cytotoxic agent
Fibrosing interstitial lung disease - Treatment with a cytotoxic agent Factor
Last reviewed for CCPS 16 December 2009.
Preliminary questions [40669]
40688 there is some evidence that treatment with a cytotoxic agent may be a factor in the development or worsening of the condition under consideration.
40962 the veteran has been treated with a cytotoxic agent at some time.
40963 the veteran was treated with a cytotoxic agent for a malignant disease or in association with haematopoietic stem cell transplantation. 40964 — the treatment with a cytotoxic agent was for treatment of an illness or injury which is identifiable. 40967 — the veteran has established the causal connection between treatment with a cytotoxic agent and VEA service for fibrosing interstitial lung disease. 40968 — the veteran has established the causal connection between treatment with a cytotoxic agent and VEA service for the clinical onset of fibrosing interstitial lung disease. 40970 — the veteran has established the causal connection between treatment with a cytotoxic agent and operational service for the clinical onset of fibrosing interstitial lung disease. or 40971 — the veteran has established the causal connection between treatment with a cytotoxic agent and eligible service for the clinical onset of fibrosing interstitial lung disease. or 40969 — the veteran has established the causal connection between treatment with a cytotoxic agent and VEA service for the clinical worsening of fibrosing interstitial lung disease. 40972 — the veteran has established the causal connection between treatment with a cytotoxic agent and operational service for the clinical worsening of fibrosing interstitial lung disease. or 40973 — the veteran has established the causal connection between treatment with a cytotoxic agent and eligible service for the clinical worsening of fibrosing interstitial lung disease. Clinical onset and operational service [40970] 40974 — the identified illness or injury, for which the veteran was treated with a cytotoxic agent, is causally related to operational service. Clinical onset and eligible service [40971] 40975 — the identified illness or injury, for which the veteran was treated with a cytotoxic agent, is causally related to eligible service. Clinical worsening and operational service [40972] 40974 — the identified illness or injury, for which the veteran was treated with a cytotoxic agent, is causally related to operational service. Clinical worsening and eligible service [40973] 40975 — the identified illness or injury, for which the veteran was treated with a cytotoxic agent, is causally related to eligible service.